Aimmune Therapeutics Inc (AIMT)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

8000 MARINA BOULEVARD BRISBANE, CA 94005-1884

Aimmune Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing treatments to protect children with food allergies from accidental exposure. Aimmune Therapeutics serves customers worldwide.

Data as of 2020-05-30
Market Cap1.084 Billion Shares Outstanding65.251 Million Avg 30-day Volume1.083 Million
P/E Ratio Dividend Yield EPS-4.44
Price/Sales1884.9 Price cash flow ratio Price free cash flow ratio-4.9
Book Value3.6 Price to Tangible Book4.72 Alpha
Short Interest Ratio % Short Interest to Float R-squared
BETA 52-week High/Low37.0 / 10.09 Stddev
View SEC Filings from AIMT instead.

View recent insider trading info

 
Aimmune Therapeutics Inc Chart by YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Check out our reporting and analysis

Funds Holding AIMT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AIMT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

7.8 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MCDADE MARK

  • Director
 34,692 2020-05-27 1

SELTZER STACEY DENENBERG

  • Director
 18,061 2020-05-27 1

ENRIGHT PATRICK G

  • Director
 6,191,535 2020-05-27 3

FALBERG KATHRYN E

  • Director
 142,926 2020-05-27 1

IWICKI MARK T

  • Director
 47,407 2020-05-27 1

BEHAR GREGORY

  • Director
 18,032 2020-05-27 1

HAUMANN BRETT K

  • Director
 19,563 2020-05-27 1

DILLY STEPHEN GEORGE

  • Director
 7,500 2020-05-18 0

NESTLE HEALTH SCIENCE US HOLDINGS, INC.

SOCIETE DES PRODUITS NESTLE S.A.

NESTLE SA

NIMCO US, INC.

NESTLE US HOLDCO, INC.

  • 10% Owner
 4,305,541 2020-05-18 0

SHEEHY DOUGLAS T. SEE REMARKS

  • Officer
 55,378 2020-05-10 6

ADELMAN DANIEL C MD CHIEF MEDICAL OFFICER

  • Officer
 29,715 2020-05-10 6

BJERKHOLT ERIC CHIEF FINANCIAL OFFICER

  • Officer
 45,387 2020-05-10 7

DALLAS JAYSON DONALD ALEXANDER PRESIDENT AND CEO

  • Officer
  • Director
 126,583 2020-05-10 5

OXTOBY ANDREW CHIEF COMMERCIAL OFFICER

  • Officer
 27,435 2020-05-10 5

TAMMENOMS BAKKER JULIET

  • FORMER DIRECTOR
 0 2020-02-14 0

SOCIETE DES PRODUITS NESTLE S.A.

NESTLE SA

  • 10% Owner
 26,505,494 2020-02-07 1

ROZENMAN MARY M. SEE REMARKS

  • Officer
 13,878 2019-12-31 1

BARROWCLIFFE SUSAN E. GENERAL MANAGER, EUROPE

  • Officer
 9,375 2018-11-19 0

LONGITUDE CAPITAL PARTNERS II, LLC

LONGITUDE VENTURE PARTNERS II, L.P.

TAMMENOMS BAKKER JULIET

ENRIGHT PATRICK G

3,019,734 2018-07-02 0

LONGITUDE CAPITAL PARTNERS II, LLC

TAMMENOMS BAKKER JULIET

LONGITUDE VENTURE PARTNERS II, L.P.

  • 10% Owner
 No longer subject to file 2018-06-25 0

KNAPP JEFFREY H CHIEF OPERATING OFFICER

  • Officer
 12,151 2018-03-04 0

NESTLE HEALTH SCIENCE US HOLDINGS, INC.

NESTLE SA

NIMCO US, INC.

  • 10% Owner
 11,727,113 2018-02-26 0

FORESITE CAPITAL MANAGEMENT II, LLC

FORESITE CAPITAL FUND II, L.P.

FORESITE CAPITAL MANAGEMENT III, LLC

FORESITE CAPITAL FUND III, L.P.

TANANBAUM JAMES B.

  • 10% Owner
 3,643,191 2017-05-26 0

DESOUZA WARREN L. CHIEF FINANCIAL OFFICER

  • Officer
 20,681 2017-04-03 0

ELFONT ROBERT MYLES CHIEF MEDICAL OFFICER

  • Officer
 299,002 2016-02-26 0

FORESITE CAPITAL MANAGEMENT II, LLC

FORESITE CAPITAL FUND II, L.P.

TANANBAUM JAMES B.

  • 10% Owner
 0 2015-08-05 0

RAFF HOWARD V. CHIEF OPERATING OFFICER

  • Officer
 428,575 2015-08-05 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

SELTZER STACEY DENENBERG - Director

2020-05-27 A 15,398 a 15,398 18,061.00 direct

MCDADE MARK - Director

2020-05-27 A 7,840 a 34,692 34,692.00 direct

FALBERG KATHRYN E - Director

2020-05-27 A 15,398 a 15,398 142,926.00 direct

HAUMANN BRETT K - Director

2020-05-27 A 13,313 a 19,563 19,563.00 direct

IWICKI MARK T - Director

2020-05-27 A 15,398 a 15,398 47,407.00 direct

SELTZER STACEY DENENBERG - Director

2020-05-27 A 7,840 a 18,061 18,061.00 direct

ENRIGHT PATRICK G - Director

2020-05-27 A 15,398 a 15,398 6,191,535.00 direct

FALBERG KATHRYN E - Director

2020-05-27 A 7,840 a 73,032 142,926.00 direct

BEHAR GREGORY - Director

2020-05-27 A 15,398 a 15,398 18,032.00 direct

IWICKI MARK T - Director

2020-05-27 A 7,840 a 47,407 47,407.00 direct

MCDADE MARK - Director

2020-05-27 A 15,398 a 15,398 34,692.00 direct

ENRIGHT PATRICK G - Director

2020-05-27 S 7,840 a 78,401 6,191,535.00 direct

HAUMANN BRETT K - Director

2020-05-27 A 25,453 a 25,453 19,563.00 direct

BEHAR GREGORY - Director

2020-05-27 A 7,840 a 18,032 18,032.00 direct

SHEEHY DOUGLAS T. - Officer SEE REMARKS

2020-05-10 A 2,420 a 55,378 55,378.00 direct

DALLAS JAYSON DONALD ALEXANDER - Director - Officer PRESIDENT AND CEO

2020-05-10 A 3,300 a 126,583 126,583.00 direct

BJERKHOLT ERIC - Officer CHIEF FINANCIAL OFFICER

2020-05-10 A 2,420 a 45,387 45,387.00 direct

OXTOBY ANDREW - Officer CHIEF COMMERCIAL OFFICER

2020-05-10 A 2,420 a 27,435 27,435.00 direct

ADELMAN DANIEL C MD - Officer CHIEF MEDICAL OFFICER

2020-05-10 A 2,420 a 29,715 29,715.00 direct

SOCIETE DES PRODUITS NESTLE S.A. - > 10% Owner see footnote

NESTLE SA - > 10% Owner see footnote

2020-04-22 J 12,727,113 $16.11 a 12,727,113 26,505,494.00 indirect

SOCIETE DES PRODUITS NESTLE S.A. - > 10% Owner see footnote

NESTLE SA - > 10% Owner see footnote

2020-04-22 J 525,634 $161.10 a 525,634 26,505,494.00 indirect

Elevate your investments